Vimarsana
Biggest News Aggregation in the World

Page 24 - Randomized Trial News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Randomized Trial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Randomized Trial Today - Breaking & Trending Today

Updated Dietary Guidelines Recommend Including Nuts/Peanuts in Childhood Diets - Vimarsana News

Updated Dietary Guidelines Recommend Including Nuts/Peanuts in Childhood Diets

Updated Dietary Guidelines Recommend Including Nuts/Peanuts in Childhood Diets Peanut Foods Can Help Fuel Development and Growth of Brain and Body News provided by Share this article ALBANY, Ga., May 11, 2021 /PRNewswire/ -- For the first time, the most recent Dietary Guidelines for Americans include recommendations for infants and toddlers, a timeframe referred to as "B24" that covers birth to 24 months. During the critical B24 period, the 2020-2025 guidelines address the beneficial role nuts/peanuts can play in the development and growth of a child's brain and body. During the critical b...

NIMH » Studies Recruiting Only Women - Vimarsana News

NIMH » Studies Recruiting Only Women

Lists NIMH clinical trials/studies that are recruiting only women.

Source: nih.gov
Biosplice Publishes Successful Clinical Trial in Knee Osteoarthritis - Vimarsana News

Biosplice Publishes Successful Clinical Trial in Knee Osteoarthritis

Biosplice Publishes Successful Clinical Trial in Knee Osteoarthritis Biosplice’s Phase 2b trial for lorecivivint hits primary endpoint in osteoarthritis pain SAN DIEGO, April 26, 2021 (GLOBE NEWSWIRE) — Biosplice Therapeutics, Inc. (“Biosplice”), a clinical-stage biotechnology company pioneering therapeutics based on alternative pre-mRNA splicing for major diseases, announced today the publication of its successful Phase 2b knee osteoarthritis clinical trial data in Osteoarthritis and Cartilage. In this 24-week clinical trial, Biosplice’s groundbreaking knee OA drug candidate, lore...

IN.PACT™ AV Drug-Coated Balloon Is First and Only to Show Superior and Sustained Results Through Two Years Compared to PTA in Treating Arteriovenous Fistulae Lesions - Vimarsana News

IN.PACT™ AV Drug-Coated Balloon Is First and Only to Show Superior and Sustained Results Through Two Years Compared to PTA in Treating Arteriovenous Fistulae Lesions

Share this article Share this article IN.PACT AV Access Trial 24 Month Results Presented as a Podium First at Charing Cross Symposium DUBLIN and LONDON, April 20, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the safety and effectiveness results through 24 months for the IN.PACT AV Access clinical study. The data, which were presented virtually as a podium first at the 2021 Charing Cross Symposium, demonstrated that the IN.PACT™ AV drug-coated balloon (DCB) is the first and only DCB to show sustained and superior effectiveness throug...

Service Dogs Better Than Emotional Support Dogs at Reducing PTSD Symptoms, Study Finds - Vimarsana News

Service Dogs Better Than Emotional Support Dogs at Reducing PTSD Symptoms, Study Finds

VA research shows that service dogs trained to address PTSD can lower symptoms.